NCT07140094 Long-Covid-19 Alleviation Through Learning Mindfulness Study
| NCT ID | NCT07140094 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Columbia University |
| Condition | Long COVID |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2024-05-21 |
| Primary Completion | 2027-05-21 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2024-05-21 with a primary completion date of 2027-05-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research is being done to study a mindfulness intervention among people who have symptoms of Post-Acute Sequelae of SARS-CoV-2 infection (PASC), also known as Long COVID. Mindfulness is defined as paying attention to the present moment with non-judgment and acceptance. Here the investigators are studying whether a mindfulness intervention can help reduce stress, reduce Long COVID symptoms, and improve quality of life among people living with Long COVID. The mindfulness intervention is a series of recorded mindfulness sessions, which were created by the study team. People who decide to take part will be randomly assigned to receive the study mindfulness intervention immediately after joining the study or to receive the study mindfulness intervention 8 weeks after joining the study. All participants will continue their usual medical care. Participants will complete online surveys to measure symptoms over time. The study will last 6 months.
Eligibility Criteria
Inclusion Criteria: * Age \> or = 18 * Willing and able to provide informed consent * Access to the internet * Self-reported history of SARS-CoV-2 infection * Current symptoms attributed to PASC by participant or by participant's medical provider; ongoing symptoms that persisted \>= 12 weeks after Covid-19 illness Exclusion Criteria: * Participating in another clinical trial of an intervention for PASC symptoms * Engaged in a structured MBI
Contact & Investigator
Deborah Theodore, MD
PRINCIPAL INVESTIGATOR
Columbia University
Frequently Asked Questions
Who can join the NCT07140094 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Long COVID. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07140094 currently recruiting?
Yes, NCT07140094 is actively recruiting participants. Contact the research team at dat2132@cumc.columbia.edu for enrollment information.
Where is the NCT07140094 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT07140094 clinical trial?
NCT07140094 is sponsored by Columbia University. The principal investigator is Deborah Theodore, MD at Columbia University. The trial plans to enroll 400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.